Aligos Therapeutics Inc (ALGS:NASDAQ)

$7.5 0.56 (8.07%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 89

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed Aligos Therapeutics Inc (ALGS:NASDAQ) News Sources

Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026

Yahoo Finance

Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)

The Manila Times

Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic ...

The Bakersfield Californian

ALGS stock
ALGS stock price
ALGS stock price today
ALGS stock prediction
ALGS earnings date
ALGS news
ALGS price
ALGS share
ALGS share price
ALGS shares
ALGS ceo
ALGS premarket
$ALGS
ALGS ticker
ALGS after hours
ALGS stock
ALGS stock price
ALGS stock price today
ALGS stock prediction
ALGS earnings date
ALGS news
ALGS price
ALGS share
ALGS share price
ALGS shares
ALGS ceo
ALGS premarket
$ALGS
ALGS ticker
ALGS after hours

Aligos Therapeutics Inc (ALGS:NASDAQ) FAQs

toggle

What is the current price of Aligos Therapeutics Inc (ALGS:NASDAQ)?

The current price of Aligos Therapeutics Inc (ALGS:NASDAQ) is $7.5.


toggle

Aligos Therapeutics Inc (ALGS:NASDAQ) absolute price change since previous trading day?

The absolute price change of Aligos Therapeutics Inc (ALGS:NASDAQ) since the previous trading day is $0.56.


toggle

Aligos Therapeutics Inc (ALGS:NASDAQ) percentage price change since previous trading day?

The percentage price change of Aligos Therapeutics Inc (ALGS:NASDAQ) since the previous trading day is 8.07%.


toggle

What is This Week's average sentiment score for Aligos Therapeutics Inc (ALGS:NASDAQ)?

This Week's average sentiment score for Aligos Therapeutics Inc (ALGS:NASDAQ) is 89 out of 100.


toggle

What is This Week's average sentiment for Aligos Therapeutics Inc (ALGS:NASDAQ)?

This Week's sentiment for Aligos Therapeutics Inc (ALGS:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.